TFF PHARMACEUTICALS, INC. Shareholders' Equity
TFF PHARMACEUTICALS, INC. had Shareholders' Equity of $3.14 million as of 2024-09-30, per its 10-Q filed 2024-11-20.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2024-11-20
- 2024-09-30: Stockholders' Equity Attributable to Parent $3.14M.
- 2024-06-30: Stockholders' Equity Attributable to Parent $5.88M.
- 2024-03-31: Stockholders' Equity Attributable to Parent $5.30M.
- 2023-12-31: Stockholders' Equity Attributable to Parent $9.57M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2024-09-30 | $3.14M 10-Q · filed 2024-11-20 |
| 2024-06-30 | $5.88M 10-Q · filed 2024-11-20 |
| 2024-03-31 | $5.30M 10-Q · filed 2024-11-20 |
| 2023-12-31 | $9.57M 10-Q · filed 2024-11-20 |
| 2023-09-30 | $13.69M 10-Q · filed 2024-11-20 |
| 2023-06-30 | $12.28M 10-Q · filed 2024-11-20 |
| 2023-03-31 | $16.54M 10-Q · filed 2024-11-20 |
| 2022-12-31 | $22.88M 10-Q · filed 2024-11-20 |
| 2022-09-30 | $18.02M 10-Q · filed 2023-11-14 |
| 2022-06-30 | $23.94M 10-Q · filed 2023-11-14 |
| 2022-03-31 | $31.59M 10-Q · filed 2023-11-14 |
| 2021-12-31 | $38.74M 10-K · filed 2024-03-28 |
| 2021-09-30 | $47.74M 10-Q · filed 2022-11-14 |
| 2021-06-30 | $55.62M 10-Q · filed 2022-11-14 |
| 2021-03-31 | $59.54M 10-Q · filed 2022-11-14 |
| 2020-12-31 | $37.34M 10-K · filed 2023-03-31 |
| 2020-09-30 | $41.58M 10-Q · filed 2021-11-15 |
| 2020-06-30 | $21.84M 10-Q · filed 2021-11-15 |
| 2020-03-31 | $25.39M 10-Q · filed 2021-11-15 |
| 2019-12-31 | $27.64M 10-K · filed 2022-03-24 |
| 2019-09-30 | -$10.84M 10-Q · filed 2020-11-05 |
| 2019-06-30 | -$7.51M 10-Q · filed 2020-11-05 |
| 2019-03-31 | -$5.52M 10-Q · filed 2020-11-05 |
| 2018-12-31 | -$3.24M 10-K · filed 2021-03-10 |
| 2018-09-30 | -$2.24M 10-Q · filed 2019-12-09 |
| 2018-06-30 | -$1.50M 10-Q · filed 2019-12-09 |
| 2018-03-31 | -$267.50K 10-Q · filed 2019-12-09 |
| 2017-12-31 | -$1.83K 10-K · filed 2020-03-27 |